Previous close | 52.82 |
Open | 54.78 |
Bid | 52.06 x N/A |
Ask | 53.22 x N/A |
Day's range | 54.36 - 54.78 |
52-week range | 47.41 - 60.92 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WILMINGTON, Del. & SAN DIEGO, May 30, 2024--Incyte Completes Acquisition of Escient Pharmaceuticals
WILMINGTON, Del., May 21, 2024--Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings
WILMINGTON, Del., May 21, 2024--Incyte (Nasdaq:INCY) announced today that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. (EDT) in Miami.